Search

Author/Creator Graham, Mark L

1. Oxybutynin vs Placebo for Hot Flashes in Women With or Without Breast Cancer: A Randomized, Double-Blind Clinical Trial (ACCRU SC-1603). Issue 1 (21st October 2019)

Authors:
Leon-Ferre, Roberto A; Novotny, Paul J; Wolfe, Eric G; Faubion, Stephanie S; Ruddy, Kathryn J; Flora, Daniel; Dakhil, Christopher S R; Rowland, Kendrith M; Graham, Mark L; Le-Lindqwister, Nguyet; Smith, Thomas J; Loprinzi, Charles L
Journal:
JNCI cancer spectrum
Issue:
Volume 4:Issue 1(2020)
Page Start:
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

2. Use of letrozole after aromatase inhibitor-based therapy in postmenopausal breast cancer (NRG Oncology/NSABP B-42): a randomised, double-blind, placebo-controlled, phase 3 trial. Issue 1 (January 2019)

Authors:
Mamounas, Eleftherios P; Bandos, Hanna; Lembersky, Barry C; Jeong, Jong-Hyeon; Geyer, Charles E; Rastogi, Priya; Fehrenbacher, Louis; Graham, Mark L; Chia, Stephen K; Brufsky, Adam M; Walshe, Janice M; Soori, Gamini S; Dakhil, Shaker R; Seay, Thomas E; Wade, James L; McCarron, Edward C; Paik, Soo...
Journal:
Lancet oncology
Issue:
Volume 20:Issue 1(2019)
Page Start:
88
Record Type:
Journal Article
View Content:
Available online (eLD content is only available in our Reading Rooms) ↗

Limit your search